• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GERMANY ARCHITECT HAVAB-IGG; IGG ANTI-HAV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GERMANY ARCHITECT HAVAB-IGG; IGG ANTI-HAV Back to Search Results
Catalog Number 06C29-22
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There is no further patient information provided due to privacy issues.This report is being filed on an international product, list number 6c29 that has a similar product distributed in the us, list number 6l27.
 
Event Description
The customer reported (b)(6) architect havab-igg results on one patient.The results provided were: sid (b)(6): initial = (b)(6) / re-centrifuged and retested = (b)(6).There was no reported impact to patient management.
 
Manufacturer Narrative
A review of tickets determined that there is a trend in complaint activity for lot number 92421li00 regarding false reactive patient results.Returns were not required for testing during the investigation.Specificity testing was performed with a retained kit of lot 92421li00 and all control values met specifications and no false reactive results were obtained.Historical performance of the architect havab igg assay was evaluated using world wide data from abbottlink.The median and the standard deviations to cutoff of the negative population was within 2 sd of the overall median and the mean standard deviations to cutoff across all lot numbers.This indicates that the lot number is performing in line with all other reagent lots in the field during the reviewed timeframe.A review of labeling concluded that the issue is adequately addressed.Based on the investigation no product deficiency was identified architect havab igg, lot 92421li00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HAVAB-IGG
Type of Device
IGG ANTI-HAV
Manufacturer (Section D)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key8388046
MDR Text Key137867790
Report Number3002809144-2019-00086
Device Sequence Number1
Product Code LOL
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 05/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/04/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/10/2019
Device Catalogue Number06C29-22
Device Lot Number92421LI00
Was Device Available for Evaluation? No
Date Manufacturer Received05/20/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER, LIST # 03M74-02,; ARCHITECT I2000SR ANALYZER, LIST # 03M74-02,; SERIAL # (B)(4).; SERIAL # (B)(4).
-
-